Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucagon effects on energy expenditure (GLEE)
NCT02237053Phase 1Completed
- Sponsor
- AdventHealth Translational Research Institute
- Start
- Sep 2014
- Primary completion
- Jun 2015
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of glucagon in obesity, sponsored by AdventHealth Translational Research Institute. Started Sep 2014; status: completed.
02
Drugs
glucagon
03
Conditions
obesity
Beyond the preview
Go deeper on NCT02237053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02237053.